|
|
![]() | ![]() | ![]() | ![]() |
This excerpt taken from the C 10-Q filed Nov 6, 2009. Recognition and Measurement of Other-Than-Temporary Impairment The following table presents the total other-than-temporary impairments recognized during the three months and nine months ended September 30, 2009: This excerpt taken from the C 10-Q filed Aug 7, 2009. Recognition and Measurement of Other-Than-Temporary Impairment AFS and HTM debt securities that have been identified as other-than-temporarily impaired are written down to their current fair value. For debt securities that are intended to be sold or that management believes more-likely-than-not will be required to be sold prior to recovery, the full impairment is recognized immediately in earnings. For AFS and HTM debt securities that management has no intent to sell and believes that it more-likely-than-not will not be required to be sold prior to recovery, only the credit loss component of the impairment is recognized in earnings, while the rest of the fair value loss is recognized in OCI. The credit loss component recognized in earnings is identified as the amount of principal cash flows not expected to be received over the remaining term of the security as projected using the Company's cash flow projections using its base assumptions. AFS equity securities deemed other-than-temporarily impaired are written down to fair value, with the full difference between fair value and amortized cost recognized in earnings. 103 The following table presents the total other-than-temporary impairments recognized during the three months and six months ended June 30, 2009: This excerpt taken from the C 10-Q filed May 11, 2009. Recognition and Measurement of Other-Than-Temporary Impairment AFS and HTM debt securities that have been identified as other-than-temporarily impaired are written down to their current fair value. For debt securities that are intended to be sold, or that management believes it is more-likely-than-not that it will be required to be sold prior to recovery, the full impairment is recognized immediately in earnings. For AFS and HTM debt securities that management has no intent to sell and believes that it is more-likely-than not that it will not be required to be sold prior to recovery, only the credit loss component of the impairment is recognized in earnings, while the rest of the fair value loss is recognized in OCI. The credit loss component recognized in earnings is identified as the amount of principal cash flows not expected to be received over the remaining term of the security as projected using the Company's cash flow projections using its base assumptions. AFS equity securities deemed other-than-temporarily impaired are written down to fair value, with the full difference between fair value and amortized cost recognized in earnings. The following table presents the total other-than-temporary impairments recognized during the first quarter of 2009. | EXCERPTS ON THIS PAGE:
RELATED TOPICS for C: |
| |||||||